Paragon 28 Inc is a medical device company focused on advancing innovation in the field of foot and ankle surgery
The company specializes in the development and commercialization of an extensive range of surgical implants and instruments designed to enhance patient outcomes and support orthopedic surgeons in their practice. Through its dedication to research and development, Paragon 28 aims to provide high-quality solutions that address various pathological conditions in the foot and ankle, enhancing both the effectiveness of surgical procedures and patient recovery.
Zimmer Biomet agrees to acquire Paragon 28 for $1.1 billion, with a non-tradeable CVR up to $1 per share. Deal expected to close in first half of 2025.
Shares of RxSight, Inc. (NASDAQRXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
U.S. stocks traded mixed, with the Dow Jones index falling around 80 points on Monday. Shares of The Boeing Company (NYSEBA) fell during Friday’s session after an exit door blew out of a 737 aircraft during a commercial flight.
